HDAC9 and pulmonary arterial hypertension: Studies of multiple HDAC inhibitors in multiple PAH models suggest that regulation of proinflammatory genes, pro-growth genes, and promigratory signaling genes are regulated by histone modifications that may well initiate and promote arteriopathy and control PAH severity.